Cystic fibrosis in South Africa: spectrum of disease and determinants of outcome Source: ERJ Open Res, 7 (3) 00856-2020; 10.1183/23120541.00856-2020 Year: 2021
Cystic fibrosis and survival to 40 years: a case–control study Source: Eur Respir J 2010; 36: 1277-1283 Year: 2010
Cystic fibrosis mortality and survival in the UK: 1947-2003 Source: Eur Respir J 2007; 29: 522-526 Year: 2007
Cystic fibrosis newborn screening programme in central Catalonia area (Spain). What have we learnt 8 years later? Source: Annual Congress 2008 - Cystic fibrosis: new mechanisms, monitoring and treatment tools Year: 2008
Predictors of non-cystic fibrosis bronchiectasis in Indigenous adult residents of central Australia: results of a case–control study Source: ERJ Open Res, 5 (4) 00001-2019; 10.1183/23120541.00001-2019 Year: 2019
Demographic and survival changes of cystic fibrosis at a CF centre over 34 years Source: Eur Respir J 2007; 30: Suppl. 51, 386s Year: 2007
Characteristics of 75 children with obliterative bronchiolitis (OB) in the South of Brazil Source: Eur Respir J 2006; 28: Suppl. 50, 265s Year: 2006
Portrait of the cystic fibrosis (CF) patient in Australia and New Zealand (NZ) in 1999 Source: Eur Respir J 2002; 20: Suppl. 38, 341s Year: 2002
Hypomagnesaemia in patients with cystic fibrosis (CF) in R. Macedonia Source: Annual Congress 2008 - Cystic fibrosis: a disease with many aspects Year: 2008
Evidence incidence of cystic fibrosis: A 30-year study in Krasnoyarsk, Russia Source: Annual Congress 2013 –Cystic fibrosis: clinical problems, genetics and microbiology in children Year: 2013
Management of cystic fibrosis patients – The South Australian lung transplant satellite centre experience Source: Annual Congress 2012 - Optimising outcomes after lung transplantation Year: 2012
Improved survival albeit with persistent disparities in prognosis for people with cystic fibrosis in European countries Source: Eur Respir J, 58 (3) 2101487; 10.1183/13993003.01487-2021 Year: 2021
The obstructive lung disease in northern Sweden (OLIN) longitudinal paediatric study I – the first 10 years Source: Annual Congress 2008 - Asthma epidemiology Year: 2008
Assessment of renal function in cystic fibrosis (CF) patients in R. Macedonia Source: Eur Respir J 2007; 30: Suppl. 51, 387s Year: 2007
Analysis of cases from an interstitial lung disease (ILD) MDT in a teaching hospital in the West Midlands: Patients with smoking-related disease comprise 11% of cases and have a median age of 50 years Source: Annual Congress 2012 - Diffuse parenchymal lung disease III Year: 2012
Outcomes at 6 months following NIV in adults with cystic fibrosis (CF): experience of a large UK centre Source: International Congress 2019 – Physiology of cystic fibrosis Year: 2019
Lung transplantation for cystic fibrosis – ten years‘ experience in Hungary Source: Eur Respir J 2007; 30: Suppl. 51, 386s Year: 2007
Mortality risk and pulmonary function in adults with cystic fibrosis at time of wait listing for lung transplantation in the United States Source: International Congress 2015 – Outcomes of lung transplantation Year: 2015
The increase in mortality from idiopathic pulmonary fibrosis in England and Wales in 1968-2008 Source: Annual Congress 2010 - Various aspects of respiratory epidemiology Year: 2010
Future trends in cystic fibrosis demography in 34 European countries Source: Eur Respir J 2015; 46: 133-141 Year: 2015